Degradation of membrane phospholipids play a crucial role in the pathophysiology of myocardial reperfusion injury. Inositol phosphates and diglycerides, novel second messengers, released from the phospholipids may be instrumental for reperfusion injury, the former causing Ca2+ release and the latter activating protein C kinase thereby initiating a cascade of reactions. Arachidonic acid released from phospholipids can also cause cellular injury in many ways. The proposed research will continue to explore the mechanisms of phospholipid breakdown in the ischemic-reperfused heart. The relative contribution of various pathways of phospholipid breakdown will be examined using specific inhibitors of rate controlling steps in each pathway, simultaneously estimating corresponding enzymes and metabolites and studying myocardial preservation during ischemia and reperfusion. In addition, the role of various mediators (transducing and regulatory proteins) for phospholipid degradation, fatty acid binding protein, lipocortin, endothelin as well as alpha and beta adrenergic receptors will be studied by blocking the actions of these mediators by specific blockers, simultaneously examining the effects on phospholipid breakdown and myocardial preservation. Breakdown of phospholipids will be monitored by estimating various phospholipids and their degradation products. To monitor minor changes in breakdown, the membrane phospholipids will be radiolabeled with various isotopes followed by subsequent analysis of incorporated radioactivities from the metabolites. A study will be conducted to examine whether free radicals, important mediators of reperfusion injury, are generated from the phospholipid degradation. The goals of this investigation are to establish the mechanism of phospholipid breakdown and to apply the knowledge gained to appropriate interventions to protect an ischemic heart from reperfusion injury. This will eventually be applicable to patient care for reduction of myocardial injury during ischemia and reperfusion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL034360-05
Application #
3347191
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1987-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Das, Somak; Mitrovsky, Goran; Vasanthi, Hannah R et al. (2014) Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014:345105
Das, Somak; Mukherjee, Subhendu; Lekli, Istvan et al. (2012) Tocotrienols confer resistance to ischemia in hypercholesterolemic hearts: insight with genomics. Mol Cell Biochem 360:35-45
(2012) Retraction. Freshly crushed garlic is a superior cardioprotective agent than processed garlic. J Agric Food Chem 60:2766
Mukhopadhyay, Partha; Pacher, Pal; Das, Dipak K (2011) MicroRNA signatures of resveratrol in the ischemic heart. Ann N Y Acad Sci 1215:109-16
Das, Dipak K; Mukherjee, Subhendu; Ray, Diptarka (2011) Erratum to: resveratrol and red wine, healthy heart and longevity. Heart Fail Rev 16:425-35
Gurusamy, Narasimman; Lekli, Istvan; Ahsan, Md Kaimul et al. (2010) Downregulation of cardiac lineage protein-1 confers cardioprotection through the upregulation of redox effectors. FEBS Lett 584:187-93
Das, Dipak K; Mukherjee, Subhendu; Ray, Diptarka (2010) Resveratrol and red wine, healthy heart and longevity. Heart Fail Rev 15:467-77
Vasanthi, Hannah Rachel; Mukherjee, Subhendu; Ray, Diptarka et al. (2010) Protective role of air potato (Dioscorea bulbifera) of yam family in myocardial ischemic reperfusion injury. Food Funct 1:278-83
Gurusamy, Narasimman; Lekli, Istvan; Mukherjee, Subhendu et al. (2010) Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res 86:103-12
Lekli, Istvan; Ray, Diptarka; Mukherjee, Subhendu et al. (2010) Co-ordinated autophagy with resveratrol and ?-tocotrienol confers synergetic cardioprotection. J Cell Mol Med 14:2506-18

Showing the most recent 10 out of 185 publications